China Dasheng Biotechnology Company
China Dasheng Biotechnology Company (CDBT) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
cdbt · pe ratio · data through Jun 30, 2023
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for China Dasheng Biotechnology Company (CDBT) measures how much investors pay for each dollar of the company's trailing earnings. CDBT's current PE ratio of 1.78x is calculated by dividing its stock price of $0.10 by its TTM earnings per share of $0.02. −85.9% discount vs 5Y avg 12.6x
Source: FMP · /ratios-ttm · /analyst-estimates · 2023-06-30
PE Ratio History
2005 – 2023 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Shell Companies · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
China Dasheng Biotechnology CompanyYou CDBT | $4M | 1.78x | — | $0.02 |
 EKIMAS Corporation ASNB | $5M | N/A | — | -$0.32 |
 Eat & Beyond Global Holdings Inc. EATBF | $5M | N/A | — | -$0.72 |
 Engage Mobility, Inc. ENGA | $4M | N/A | — | — |
 EZRaider Co. EZRG | $42M | N/A | — | -$0.06 |
 Fuel Doctor Holdings, Inc. FDOC | $3M | N/A | — | -$0.04 |
 Global Developments, Inc. GDVM | $2M | N/A | — | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2023-06-30Latest FY2023 | — | $-0.02 | — | |
2022-06-30 FY2022 | — | $0.00 | — | |
2008-06-30 FY2008 | 12.61x | $0.15 | — | |
2007-10-31 FY2007 | — | $-0.01 | — | |
2006-10-31 FY2006 | — | $-0.00 | — | |
2005-10-31 FY2005 | — | $-0.00 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for China Dasheng Biotechnology Company (CDBT) measures how much investors pay for each dollar of the company's trailing earnings. CDBT's current PE ratio of 1.78x is calculated by dividing its stock price of $0.10 by its TTM earnings per share of $0.02.
Frequently asked questions
CDBT pe ratio · 6 questionsCDBT's current PE ratio is 1.78x as of 2026-06-09, based on a stock price of $0.10 and TTM EPS of $0.02. Data sourced from Financial Modeling Prep via CDBT's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · China Dasheng Biotechnology Company SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09